Yıl: 2021 Cilt: 30 Sayı: 2 Sayfa Aralığı: 204 - 211 Metin Dili: İngilizce DOI: 10.37845/ret.vit.2021.30.37 İndeks Tarihi: 18-05-2022

Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial

Öz:
Purpose: The vitreous concentration of Hypoxia-inducible Factor-1α (HIF-1α) and Intercellular Adhesive Molecule-1 (ICAM-1) were related to the permeability of retinal vessels and the grades of macular edema in proliferative diabetic retinopathy (PDR). Prior studi es have showed that pan-retinal photocoagulation (PRP) is beneficial in treating PDR. The aim of this study is to determine how pre-treatment with PRP before vitrectomy affect the vitreous level of HIF–1 and ICAM-1 in patients with PDR. Materials and Methods: A randomized clinical trial study was conducted to 22 eyes in Cipto Mangunkusumo National General Hospital, Indonesia. At the beginning of PRP, just before vitrectomy, and at 2, 4, and 12 weeks after vitrectomy, central macular thickness (CMT) was measured using optical coherence tomography (OCT). Undiluted vitreous humour was extracted during vitrectomy to obtain HIF-1 α and ICAM-1 concentration. Results: In the control and the photocoagulation group, the average level of HIF-1α (ng/mL) were 0.152±0.015 and 0.164±0.033 respectively. The average level of ICAM-1 (ng/mL) in control group and pre-treated group were 17,840±14,140 and 27,027±10,452 respectively. No statistically significant difference was seen in the level of HIF-1α and ICAM-1 between each group. The correlation between vitreous ICAM- 1 and HbA1c was statistically signi ficant (r=0.463, p=0.03). No signi ficant differences for CMT at pre-vitrectomy, or 2 and 4 weeks after vitrectomy. Statistically significant difference was observed at 12 weeks after follow-up (p=0.049). The correlation between vitreous level of HIF-Iα and CMT in the control and laser group are r = 0.447 and r = 0.32, respectively. Conclusion: Laser photocoagulation 1-2 weeks prior to vitrectomy did not lower vitreous concentration of HIF-1α and ICAM-1.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik
  • 1. Heng LZ, Comyn O, Peto T, Tadros C, Ng E, Sivaprasad S, et al. Diabetic retinopathy: pathogenesis, clinical grading, management and future developments - Review Article. Diabet Med. 2013;30:640-50.
  • 2. Tarr J, Kaul K, Chopra M, M Kohner E, Chibber R. Pathophysiology of Diabetic Retinopathy. ISRN Ophthalmol. 2013;2013:1-13.
  • 3. Domingueti CP, Dusse LM, das Graças Carvalho M, de Sousa LP, Gomes KB, Fernandes AP. Diabetes mellitus: the linkage between oxidative stress, in flammation, hypercoagulability and vascular complications. J Diabetes Complications. 2016;30:738-45.
  • 4. Antonetti DA, Klein R, Gardner TW. Mechanism of disease diabetic retinopathy: Review. N Engl J Med. 2012;366:1227-39.
  • 5. Chistiakov DA. Diabetic retinopathy: pathogenic mechanisms and current treatments. Diabetes Metab Syndr. 2011;5:165-72.
  • 6. Girgis CM, Cheng K, Scott CH, Gunton JE. Novel links between HIFs, type 2 diabetes, and metabolic syndrome. Trends Endocrinol Metab. 2012;23(8):372-80.
  • 7. Loukovaara S, Koivunen P, Inglés M, Escobar J, Vento M, Andersson S. Elevated protein carbonyl and HIF-1 α levels in eyes with proliferative diabetic retinopathy. Acta Ophthalmol. 2014;92:323-7.
  • 8. Kurihara T. Roles of hypoxia response in retinal development and pathophysiology. Keio J Med. 2018;67:1-9.
  • 9. Adamiec-Mroczek J, O ficjalska-Młyńczak J, Misiuk-Hoj ło M. Proliferative diabetic retinopathy—The in fluence of diabetes control on the activation of the intraocular molecule system. Diabetes Res Clin Pract. 2009;84:46-50.
  • 10. Funatsu H, Noma H, Mimura T, Eguchi S, Hori S. Association of vitreous in flammatory factors with diabetic macular edema. Ophthalmology. 2009;116:73-9.
  • 11. Abcouwer SF. Angiogenic Factors and Cytokines in Diabetic Retinopathy. J Clin Cell Immunol. 2013; Suppl 1:1-12.
  • 12. Shimura M, Yasuda K, Nakazawa T, Shiono T, Nishida K. Panretinal-photocoagulation before pars plana vitrectomy influences vitreous level of interleukin-6 but not of vascular endothelial growth factor in patients with diabetic retinopathy. Int J Biomed Sci. 2007;3:31-7.
  • 13. ETDRS. Photocoagulation for diabetic macular edema. ETDRS Report Number 1. Arch Opthalmol. 1985;103:1796-806.
  • 14. ETDRS. Early photocoagulation for diabetic retinopathy. ETDRS Report Number 9. Ophthalmology. 1991;98:766-85.
  • 15. Bressler NM, Beck RW, Ferris FL 3rd. Panretinal photocoagulation for proliferative diabetic retinopathy. New Engl J Medicine. 2011;365(16):1520-6.
  • 16. Evans JR, Michelessi M, Virgili G. Laser photocoagulation for proliferative diabetic retinopathy. Cochrane Database Syst Rev. 2014(11):7-8.
  • 17. Shimura M, Yasuda K, Nakazawa T, Abe T, Shiono T, Iida T, et al. Panretinal photocoagulation induces pro-in flammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy. Graefes Arc Clin Exp Ophthalmol. 2009;247:1617-24
  • 18. Chen MS, Chang CC, Lin CP, Wang PC, Lin LR, Hou PK, et al. Role of vascular endothelial growth factor in the breakdown of the blood-aqueous barrier after retinal laser photocoagulation in pigmented rabbits. J Ocular Pharmacol Ther. 2012;28:83-8.
  • 19. Wang X, Wang G, Wang Y. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy. Am J Ophthalmol. 2009;148:883–9.
  • 20. Filek R, Hooper P, Sheidow T, Gonder J, Varma DK, Heckler L, et al. Structural and functional changes to the retina and optic nerve following panretinal photocoagulation over a 2-year time period. Eye (Lond). 2017;31:1237-44.
  • 21. Torp TL, Kawasaki R, Wong TY, Peto T, Grauslund J. Changes in retinal venular oxygen saturation predict activity of proliferative diabetic retinopathy 3 months after panretinal photocoagulation. Br J Ophthalmol. 2018;102:383-7.
  • 22. Iwase T, Mikoshiba Y, Ra E, Yamamoto K, Ueno Y, Terasaki H. Evaluation of blood flow on optic nerve head after pattern scan and conventional laser panretinal photocoagulation. Medicine. 2019;98: 7-8.
  • 23. Chidlow G, Shibeeb OS, Plunkett M, Casson RJ, Wood JPM. Glial Cell and In flammatory Responses to Retinal Laser Treatment: Comparison of a Conventional Photocoagulator and a Novel, 3-Nanosecond Pulse Laser. Invest Ophthalmol Vis Sci. 2013;54:2319-32.
  • 24. Bandello F, Lattanzio R, Zucchiatti I, Del Turco C. Pathophysiology and treatment of diabetic retinopathy. Acta Diabetologica. 2013;50:1-20.
  • 25. Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmology. 2009;54:1-32.
  • 26. McDonald H, Schatz H. Macular edema following panretinal photocoagulation. Retina. 1985;5:5-10.
  • 27. Shimura M, Yasuda K, Nakazawa T. Panretinal photocoagulation induces pro- inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2009;247:1617-24.
APA VİCTOR A, YANDANDRİ V, GONDOWİARDJO T, DHARMA R, Widia A Jusman S, PRİHARTONO J (2021). Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial. , 204 - 211. 10.37845/ret.vit.2021.30.37
Chicago VİCTOR Andi Arus,YANDANDRİ Vivi Rizka,GONDOWİARDJO Tjahjono Darminto,DHARMA Rahayuningsih,Widia A Jusman Sri,PRİHARTONO Joedoe Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial. (2021): 204 - 211. 10.37845/ret.vit.2021.30.37
MLA VİCTOR Andi Arus,YANDANDRİ Vivi Rizka,GONDOWİARDJO Tjahjono Darminto,DHARMA Rahayuningsih,Widia A Jusman Sri,PRİHARTONO Joedoe Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial. , 2021, ss.204 - 211. 10.37845/ret.vit.2021.30.37
AMA VİCTOR A,YANDANDRİ V,GONDOWİARDJO T,DHARMA R,Widia A Jusman S,PRİHARTONO J Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial. . 2021; 204 - 211. 10.37845/ret.vit.2021.30.37
Vancouver VİCTOR A,YANDANDRİ V,GONDOWİARDJO T,DHARMA R,Widia A Jusman S,PRİHARTONO J Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial. . 2021; 204 - 211. 10.37845/ret.vit.2021.30.37
IEEE VİCTOR A,YANDANDRİ V,GONDOWİARDJO T,DHARMA R,Widia A Jusman S,PRİHARTONO J "Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial." , ss.204 - 211, 2021. 10.37845/ret.vit.2021.30.37
ISNAD VİCTOR, Andi Arus vd. "Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial". (2021), 204-211. https://doi.org/10.37845/ret.vit.2021.30.37
APA VİCTOR A, YANDANDRİ V, GONDOWİARDJO T, DHARMA R, Widia A Jusman S, PRİHARTONO J (2021). Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial. Retina-Vitreus, 30(2), 204 - 211. 10.37845/ret.vit.2021.30.37
Chicago VİCTOR Andi Arus,YANDANDRİ Vivi Rizka,GONDOWİARDJO Tjahjono Darminto,DHARMA Rahayuningsih,Widia A Jusman Sri,PRİHARTONO Joedoe Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial. Retina-Vitreus 30, no.2 (2021): 204 - 211. 10.37845/ret.vit.2021.30.37
MLA VİCTOR Andi Arus,YANDANDRİ Vivi Rizka,GONDOWİARDJO Tjahjono Darminto,DHARMA Rahayuningsih,Widia A Jusman Sri,PRİHARTONO Joedoe Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial. Retina-Vitreus, vol.30, no.2, 2021, ss.204 - 211. 10.37845/ret.vit.2021.30.37
AMA VİCTOR A,YANDANDRİ V,GONDOWİARDJO T,DHARMA R,Widia A Jusman S,PRİHARTONO J Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial. Retina-Vitreus. 2021; 30(2): 204 - 211. 10.37845/ret.vit.2021.30.37
Vancouver VİCTOR A,YANDANDRİ V,GONDOWİARDJO T,DHARMA R,Widia A Jusman S,PRİHARTONO J Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial. Retina-Vitreus. 2021; 30(2): 204 - 211. 10.37845/ret.vit.2021.30.37
IEEE VİCTOR A,YANDANDRİ V,GONDOWİARDJO T,DHARMA R,Widia A Jusman S,PRİHARTONO J "Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial." Retina-Vitreus, 30, ss.204 - 211, 2021. 10.37845/ret.vit.2021.30.37
ISNAD VİCTOR, Andi Arus vd. "Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial". Retina-Vitreus 30/2 (2021), 204-211. https://doi.org/10.37845/ret.vit.2021.30.37